Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119,321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045.
Kim YN, Joung JG, Park E, Kim JW, Lee JB, Lim J, Kim S, Choi CH, Kim HS, Chung J, Kim BG, Lee JY. Kim YN, et al. Among authors: kim bg, kim s, kim hs, kim jw. Int J Cancer. 2023 Dec 15;153(12):2032-2044. doi: 10.1002/ijc.34696. Epub 2023 Aug 21. Int J Cancer. 2023. PMID: 37602928 Clinical Trial.
Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition.
Lee JK, Hong JH, Kang S, Kim DY, Kim BG, Kim SH, Kim YM, Kim JW, Kim JH, Kim TJ, Kim HJ, Kim HS, Ryu HS, Song JY, Ahn HS, Yoo CW, Yoon HK, Lee KH, Lee A, Lee Y, Lee IH, Lee JW, Lee TS, Lim MC, Chang SJ, Chung HH, Ju W, Joo HJ, Hur SY, Hong SR, Nam JH. Lee JK, et al. Among authors: kim hj, kim ym, kim dy, kim bg, kim sh, kim tj, kim hs, kim jw, kim jh. J Gynecol Oncol. 2013 Apr;24(2):186-203. doi: 10.3802/jgo.2013.24.2.186. Epub 2013 Apr 5. J Gynecol Oncol. 2013. PMID: 23653837 Free PMC article.
Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study.
Kang S, Nam JH, Bae DS, Kim JW, Kim MH, Chen X, No JH, Lee JM, Kim JH, Watari H, Kim SM, Kim SH, Seong SJ, Kim KT, Kim SC, Kim JH, Lim MC, Lee JY, Ryu SY, Yang B, Kim BG. Kang S, et al. Among authors: kim sc, kim sh, kim bg, kim kt, kim sm, kim mh, kim jw, kim jh. Cancer. 2017 Jan 1;123(2):263-272. doi: 10.1002/cncr.30349. Epub 2016 Nov 7. Cancer. 2017. PMID: 28067948 Free article.
Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D.
Park J, Lee JB, Lim MC, Kim BG, Kim JW, Kim S, Choi CH, Kim HS, Park SY, Lee JY; KGOG investigators. Park J, et al. Among authors: kim bg, kim s, kim hs, kim jw. J Immunother Cancer. 2023 Oct;11(10):e007444. doi: 10.1136/jitc-2023-007444. J Immunother Cancer. 2023. PMID: 37865397 Free PMC article. Clinical Trial.
Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial.
Kim SI, Joung JG, Kim YN, Park J, Park E, Kim JW, Lee S, Lee JB, Kim S, Choi CH, Kim HS, Lim J, Chung J, Kim BG, Lee JY. Kim SI, et al. Among authors: kim yn, kim bg, kim s, kim hs, kim jw. Gynecol Oncol. 2024 Mar;182:7-14. doi: 10.1016/j.ygyno.2023.12.029. Epub 2024 Jan 20. Gynecol Oncol. 2024. PMID: 38246047 Clinical Trial.
119,321 results
You have reached the last available page of results. Please see the User Guide for more information.